Cargando…
The spliceosome pathway activity correlates with reduced anti-tumor immunity and immunotherapy response, and unfavorable clinical outcomes in pan-cancer
Alterations in the spliceosome pathway (SP) have been associated with diverse human cancers. In this study, we explored associations of the SP activity with various clinical features, anti-tumor immune signatures, tumor immunity-related genomic and molecular features, and the response to immunothera...
Autores principales: | Chen, Zuobing, Chen, Canping, Li, Lin, Zhang, Tianfang, Wang, Xiaosheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501672/ https://www.ncbi.nlm.nih.gov/pubmed/34667536 http://dx.doi.org/10.1016/j.csbj.2021.09.029 |
Ejemplares similares
-
The mutation in splicing factor genes correlates with unfavorable prognosis, genomic instability, anti-tumor immunosuppression and increased immunotherapy response in pan-cancer
por: Luo, Jiangti, et al.
Publicado: (2023) -
Pan-Cancer Analysis Reveals That E1A Binding Protein p300 Mutations Increase Genome Instability and Antitumor Immunity
por: Chen, Zuobing, et al.
Publicado: (2021) -
Identification of novel pathways and immune profiles related to sarcopenia
por: Abdelrahman, Zeinab, et al.
Publicado: (2023) -
Identification of COVID-19 subtypes based on immunogenomic profiling
por: Chen, Zuobing, et al.
Publicado: (2021) -
KALRN mutations promote antitumor immunity and immunotherapy response in cancer
por: Li, Mengyuan, et al.
Publicado: (2020)